methyl 4-[2-(5-chloro-1-(3,4-dichlorobenzyl)-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethoxy]benzoate | 934286-08-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 4-[2-(5-chloro-1-(3,4-dichlorobenzyl)-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethoxy]benzoate
• 英文别名: Methyl 4-[2-[5-chloro-1-[(3,4-dichlorophenyl)methyl]-2-(2-methylsulfonyloxyethyl)indol-3-yl]ethoxy]benzoate
• CAS: 934286-08-5
• 化学式: C₂₈H₂₆Cl₃NO₆S
• 分子量: 610.943
• InChiKey: CLCNVTHHLJGPKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  39
• 可旋转键数：
  12
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  92.2
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  methyl 4-[2-(5-chloro-1-(3,4-dichlorobenzyl)-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethoxy]benzoate 在 sodium azide 作用下， 以 二甲基亚砜 为溶剂， 以88%的产率得到methyl 4-{2-[2-(2-azidoethyl)-5-chloro-1-(3,4-dichlorobenzyl)-1H-indol-3-yl]ethoxy}benzoate
  参考文献：
  名称：

  Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α₂α

  摘要：

  The synthesis and structure-activity relationship of a series of indole inhibitors of cytosolic phospholipase A(2)alpha (cPLA(2)alpha, type IVA phospholipase) are described. Inhibitors of cPLA(2)alpha are predicted to be efficacious in treating asthma as well as the signs and symptoms of osteoarthritis, rheumatoid arthritis, and pain. The introduction of a benzyl sulfonamide substituent at C2 was found to impart improved potency of these inhibitors, and the SAR of these sulfonamide analogues is disclosed. Compound 123 (Ecopladib) is a sub-micromolar inhibitor of cPLA(2)alpha in the GLU micelle and rat whole blood assays. Compound 123 displayed oral efficacy in the rat carrageenan air pouch and rat carrageenan-induced paw edema models.

  DOI：

  10.1021/jm061131z
• 作为产物：
  描述：

  4-(2,2-二乙氧基乙氧基)-苯甲酸甲酯 在 三乙基硅烷 、 四丁基氟化铵 、 水 、 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 72.0h， 生成 methyl 4-[2-(5-chloro-1-(3,4-dichlorobenzyl)-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethoxy]benzoate
  参考文献：
  名称：

  Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α₂α

  摘要：

  The synthesis and structure-activity relationship of a series of indole inhibitors of cytosolic phospholipase A(2)alpha (cPLA(2)alpha, type IVA phospholipase) are described. Inhibitors of cPLA(2)alpha are predicted to be efficacious in treating asthma as well as the signs and symptoms of osteoarthritis, rheumatoid arthritis, and pain. The introduction of a benzyl sulfonamide substituent at C2 was found to impart improved potency of these inhibitors, and the SAR of these sulfonamide analogues is disclosed. Compound 123 (Ecopladib) is a sub-micromolar inhibitor of cPLA(2)alpha in the GLU micelle and rat whole blood assays. Compound 123 displayed oral efficacy in the rat carrageenan air pouch and rat carrageenan-induced paw edema models.

  DOI：

  10.1021/jm061131z